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Chronic hypoxic stress induces epigenetic modifications mainly DNA methylation in
cardiac fibroblasts, inactivating tumor suppressor genes (RASSF1A) and activating
kinases (ERK1/2) leading to fibroblast proliferation and cardiac fibrosis. The Ras/ERK
signaling pathway is an intracellular signal transduction critically involved in fibroblast
proliferation. RASSF1A functions through its effect on downstream ERK1/2. The
antioxidant enzyme, extracellular superoxide dismutase (EC-SOD), decreases oxidative
stress from chronic hypoxia, but its effects on these epigenetic changes have not been
fully explored. To test our hypothesis, we used an in-vitro model: wild-type C57B6 male
mice (WT) and transgenic males with an extra copy of human hEC-SOD (TG). The studied
animals were housed in hypoxia (10% O2 ) for 21 days. The right ventricular tissue was
studied for cardiac fibrosis markers using RT-PCR and Western blot analyses. Primary
C57BL6 mouse cardiac fibroblast tissue culture was used to study the in-vitro model, the
downstream effects of RASSF-1 expression and methylation, and its relation to ERK1/2.
Our findings showed a significant increase in cardiac fibrosis markers: Collagen 1, alpha
smooth muscle actin (ASMA), and SNAIL, in the WT hypoxic animals as compared to
the TG hypoxic group (p < 0.05). The expression of DNA methylation enzymes (DNMT
1&3b) was significantly increased in the WT hypoxic mice as compared to the hypoxic
TG mice (p < 0.001). RASSF1A expression was significantly lower and ERK1/2 was
significantly higher in hypoxia WT compared to the hypoxic TG group (p < 0.05). Use
of SiRNA to block RASSF1A gene expression in murine cardiac fibroblast tissue culture
led to increased fibroblast proliferation (p < 0.05). Methylation of the RASSF1A promoter
region was significantly reduced in the TG hypoxic group compared to the WT hypoxic
group (0.59 vs. 0.75, respectively). Based on our findings, we can speculate that EC-SOD
significantly attenuates RASSF1A gene methylation and can alleviate cardiac fibrosis
induced by hypoxia.
Keywords: hypxoia, cardiac fibrosis, EC-SOD, methylation, RASSF1A
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INTRODUCTION

cellular proliferation (6). In cardiac myocytes, RASSF1A can
prevent hypertrophy through disruption of Ras/Raf-1/ERK
MAPK signaling. RASSF1A also activates Mst1 to elicit apoptosis.
In cardiac fibroblasts, RASSF1A represses NF-κB transcriptional
activity and inhibits TNF-α production and secretion, thereby
preventing paracrine-mediated hypertrophic signaling between
fibroblasts and myocytes. This mechanism involves multiple
cell types and paracrine signaling including calcineurin/NFAT,
HDAC/MEF2, and MEK/ERK pathways, which have been
elucidated in cardiac myocytes (7).
DNA methylation-mediated silencing of RASSF1A, and
subsequent activation of ERK1/2, can lead to activation of
fibroblasts and fibroblast proliferation (6). Another contributing
mechanism to cardiac dysfunction induced by hypoxia is
myofilament modification. Two myosin heavy chain (MHC)
isoforms, MHC-α and MHC-β, are expressed in the mouse heart.
α-MHC has higher intrinsic adenosine triphosphatase (ATPase)
activity and hence contributes to higher contractility, while βMHC has lower intrinsic ATPase activity and has a greater
economy of force maintenance (8). Hypoxia has been shown to
cause switching of myosin heavy chains (MHC) from its alpha
to beta isoform, thereby decreasing ATPase activity and overall
force of contraction (4).
Hypoxia and reactive oxygen species (ROS) play a pivotal
role both in the pathogenesis of hypoxia-induced pulmonary
hypertension and in the development of cardiac fibrosis (9–
13). The role of ROS, as a trigger of DNA methylation
of tumor suppressor gene promoters in carcinogenesis, was
shown in previous studies. In human breast cancer, it increases
redox concentration (e.g., hydrogen peroxide), induces the
overexpression of epigenetic modifiers, including DNMT1 and
HDAC1, inhibits gene expression, including tumor suppression;
and enhances the expression of epithelial to mesenchymal
transition inducer genes, including Snail and Slug (5, 14).
The inflammatory response mediated by extracellular reactive
oxygen generated from repetitive ischemia/reperfusion in a
murine model plays a critical role in the pathogenesis of fibrotic
remodeling and ventricular dysfunction (7). Supplementation
with vitamins E, C, and A have provided antioxidant protection
against cardiomyocyte death and have improved survival
in congestive heart failure models and doxorubicin-induced
injury (11). Doxorubicin causes cardiotoxicity through the
generation of ROS (11). ROS generated by doxorubicin include
superoxide, hydrogen peroxide, hydroxyl radical, peroxynitrite,
and lipid hydroperoxide, which are messengers for signaling
apoptotic cell death (11). In-vitro cardiomyocyte studies suggest
that superoxide dismutase-like and glutathione peroxidaselike compounds can protect against free radical production
and cellular apoptosis due to doxorubicin (6). EC-SOD is an
important antioxidant throughout the cardiovascular system and
has been shown to protect the heart from ischemic damage,
hypertrophy, and inflammation (15–17). Studies show that
human populations with a mutation in the matrix-binding
domain of EC-SOD, which diminishes its affinity for the
extracellular matrix, have a higher risk for the development
of cardiovascular and ischemic heart disease (4). EC-SOD
is important in the prevention of oxidative injury that may

Cardiac fibrosis can develop following a variety of stimuli,
including ischemia, volume overload, pressure overload, and
hypoxia (1). A common feature of all these stimuli is the
reduced availability of oxygen. Whether from decreased oxygen
delivery or from increased oxygen consumption, tissue hypoxia is
associated with infiltration of inflammatory cells and activation
of resident cells (2). Cardiac fibroblasts, the main resident
cells, are activated and transform to myofibroblasts, which are
the key driver for the fibrotic response. Other cell types act
indirectly by secreting fibrogenic mediators (macrophages, mast
cells, lymphocytes, cardiomyocytes, and vascular cells). Oxidative
stress regulates collagen synthesis and matrix metalloproteinase
activity in cardiac fibroblasts. Oxidative stress activates mitogenactivated protein kinases and stress-responsive protein kinases
(3). Markers of cardiac fibrosis include collagen I and III, alpha
smooth muscle actin (ASMA), and SNAIL (4). Cardiac fibrosis
leads to both systolic and diastolic dysfunction and increases
cell death and damage by inflammatory mediators. Prognosis
depends on the etiology and extent of the disease, with some
cases caused by chronic hypoxia showing some reversibility of
fibrosis (4).
DNA methylation is an epigenetic modification, which plays
an important role in the cellular response to chronic hypoxia
and the progression of cardiac fibrosis (2). DNA methylation
alters the chromatin structure leading to repression of gene
expression. The methylation process is regulated by a family
of DNA methyltransferase (DNMT) enzymes. Studies have
demonstrated significant increases in the activities of DNMT1
(the enzyme responsible for maintaining the methylation status
of daughter cells during cell cycle) and DNMT 3B (de novo
methylating enzyme) in response to hypoxia (2). The hypoxiainduced expression of DNMT1 and DNMT 3B is in part
regulated by hypoxia-inducible transcription factor 1α (HIF1α), through specific hypoxic response elements present in the
promoter sequence of DNMT1 and 3B (2). Their increased
activity correlates positively with the degree of cardiac fibrosis
(2). This suggests the role for epigenetic modification in fibrosis
secondary to hypoxia (2).
Ras association domain family 1 isoform A (RASSF1A)
is a tumor suppressor gene, and alterations in its regulation
are frequently seen in cardiac fibrosis (2). RASSF1A inhibits
proliferation by inhibiting the accumulation of cyclin D1 and
arresting cell division and promotes apoptosis (5).
RASSF1A functions through its effect on downstream
proteins such as extracellular signal-regulated kinases (ERK1/2).
The Ras/ERK signaling pathway has been recognized as an
intracellular signal transduction critically involved in fibroblast
proliferation. Ras/ERK1/2 is activated in cardiac fibroblasts by
platelet-derived growth factor-BB (PDGF-BB) and promotes

Abbreviations: RASSF1A, Ras association domain family 1 isoform A;
ERK1/2, Extracellular signal regulated kinases; EC-SOD, Extracellular superoxide
dismutase; ROS, reactive oxygen species; WT, Wild type; TG, Transgenic; DNMT,
DNA methyltransferase; SNAIL, Zinc finger protein SNAI1; MHC, Myosin Heavy
chains; Col, Collagen; ASMA, Alpha smooth muscle actin.
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amplification and detection were carried out using Roche
Applied Science LightCycler 480 PCR Systems with software.
The PCR cycling program consisted of 45 three-step cycles of
15 s/95◦ C, 1 min/57◦ C, 1 s/72◦ C. Relative changes in mRNA
expression were calculated as fold changes (normalized using
Gapdh) by using the comparative Ct (11Ct) method (22).

contribute to cardiac remodeling, in myocardial infarction
models, and alter ex vivo heart function (16, 17). EC-SOD
overexpression has also been shown to decrease the fibrosis that
develops in cardiac tissue secondary to ischemia–reperfusion
injury (10, 18). However, the specific mechanisms by which
EC-SOD protects against fibrosis and tissue damage, in various
organs including the lung and heart, remain unclear. Also,
the relation between EC-SOD and epigenetic changes has
not been fully explored. In this study, we reveal the effects
of overexpression of EC-SOD on cardiac fibrosis, epigenetic
changes, and myofilament changes due to chronic hypoxic stress.

Immunohistochemistry—Collagen 1 (Cy 3)
Right ventricular tissue, fixed in 4% paraformaldehyde for 24 h,
was processed, embedded in paraffin, and subsequently cut
into 4-µm-thick sections. The slides then underwent heatmediated antigen retrieval followed by incubation with primary
antibody anti-Collagen 1 antibody-3G3 (Abcam ab88147) and
secondary antibody AffiniPure Goat Anti-Mouse IgG (Jackson
ImmunoResearch Lab Inc, Code 115005003). The slides were
then analyzed using an Olympus FluoView FV300 Confocal
Laser Scanning Microscope (Thermo Fisher Scientific), and
the Fiji image processing software (an open-source platform
for biological image analysis) was used for analysis of pixel
density (23).

MATERIALS AND METHODS
In-vivo Studies
All experiments involving animals were reviewed and approved
by the Institutional Animal Care and Use Committee of the
Feinstein Institute for Medical Research. Adult (8–10-week-old)
C57BL6 male mice (wild type—WT) and transgenic neonate
mice, with an extra copy of the human EC-SOD gene containing
a β-actin promoter (TG), were housed in a pathogen-free
environment under standard light and dark cycles, with free
access to food and water (19). hEC-SOD TG mice with C57BL6
background were studied before, by us and other researchers, and
have been well-characterized (19, 20). TG mice act and behave
similarly under normal conditions (room air), like WT mouse
strains as shown in many studies before (19, 20).

Western Blot Analysis
Frozen right ventricular tissues were homogenized, and protein
extraction was carried out using a total protein extraction
Kit (BioChain Institute, Inc. Hayward, CA). The protein
concentration was evaluated using the Modified Lowry Protein
Assay (Thermo Fisher Scientific, Rockford, IL, USA). Samples
were prepared for SDS-PAGE in Laemmli sample buffer (BioRad, Hercules, CA, USA) and processed as previously described
(23). Membranes were briefly washed and immediately incubated
with the respective primary antibody in 5% BSA with phosphatebuffered saline with Tween 20 (PBST), overnight. Following
washing with PBST, the membranes were incubated with
horseradish peroxidase-conjugated secondary antibodies for 40–
60 min. The membranes were washed and then processed using
Amersham ECL detection systems (GE Healthcare, Piscataway,
NJ, USA). The membranes were immediately exposed to 8610
Fuji X-Ray Film. The films were assessed using Quantity One 1D Analysis Software on a GS-800 Calibrated Densitometer. The
density of each band is presented as a ratio in comparison to
the Actin band density. Primary antibodies were used to detect
the following markers: Collagen 1, Alpha Smooth Muscle Actin,
SNAIL, DNMT1 and 3b, and HIF1α (each obtained from Abcam,
Cambridge, MA); RASSF1A (Origene, Rockville, MD); and ERK
1/2 (Cell Signaling Technology, Danvers, MA, USA).

Animals
The studied animals were divided into three groups, Group A:
WT mice housed in room air; Group B: WT mice housed in
10% normobaric oxygen for 21 days using a BioSpherix chamber
(Lacona, NY, USA) (WT hypoxic group); and Group C: TG mice
housed under the same hypoxic conditions as Group B (18). After
21 days, the animals were euthanized under a surgical plane of
anesthesia [Fentanyl/Xylazine (5:1)] (21), and right ventricular
tissue was harvested for analysis.

RT-qPCR
Gene expression, within the right ventricular tissue samples, was
assessed following tissue disruption and homogenization. RNA
was then extracted from the tissue using the AllPrep DNA/RNA
extraction kit (Qiagen), according to the manufacturer’s
instructions. First-strand cDNA synthesis was carried out
using SuperScript II RT (Invitrogen). Quantitative real-time
PCR primers were designed so that one of each primer
pair was exon/exon boundary spanning to ensure that only
mature mRNA was amplified. The sequences of the genespecific primers used were ASMA, 5′ -aatgagcgtttccgttgc
3′ (forward), 5′ -atccccgcagactccatac-3′ (reverse); collagen
1a 1 (COL1A1), 5′ -catgttcagctttgtggacct 3′ (forward), 5′
gcagctgacttcagggatgt 3′ (reverse); collagen 3 a 1 (COL 3A1),
5′ tcccctggaatctgtgaatc 3′ (forward), 5′ tgagtcgaattggggagaat 3′
(reverse); α-Myosin Hea vy Chain (Myh6) 5′ cgcatcaaggagctcacc3′ (forward), 5′ -cctgcagccgcattaagt-3′ (reverse); and β-Myosin
Heavy Chain (Myh7) 5′ -cgcatcaaggagctcacc-3′ (forward),
5′ -ctgcagccgcagtaggtt-3′ (reverse). Q-PCR was performed;
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ROS Assay
Intracellular ROS was assessed using a cell-based assay for
measuring hydroxyl, peroxyl, or other reactive oxygen species.
The assay employs the cell-permeable fluorogenic probe 2′ ,7′ dichlorodihydrofluorescein diacetate (DCFH-DA) (Cell Biolabs,
San Diego, CA).

In-vitro Analysis
Primary C57BL6 Mouse Cardiac Fibroblasts (MCF) (Cell
Biologics, Chicago, IL, Catalog No. C57-6049) were grown to
confluence in T75 flasks using the fibroblast growth medium
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Mannheim). Cell counts were performed using a hemocytometer
24 and 48 h later.

(Cell Biologics, Chicago, IL, Catalog No. M2267), in a humidified
incubator (37◦ C, 5% CO2 ). Cells were seeded to six-well tissue
culture plates, at a density of 10,000 cells per well, and incubated
for 24 h. Next, the cells were transfected with human ECSOD (hEC-SOD) cDNA inserted into a vector plasmid pcDNA3
(5446 nucleotides; Invitrogen Life Technologies, Carlsbad, CA,
USA) as previously described (13), using the FuGENE kit
(Roche Diagnostics, Indianapolis, IN, USA). Each well received
1 µg DNA/100 µL serum-free medium of the DNA/FuGENE
complex. Control wells received the serum-free medium alone.
Transfected cells were selected using Geneticin (Invitrogen Life
Technologies). Transfection of the fibroblasts was confirmed by
Western blot analysis using an antibody specific for hEC-SOD
(R&D Systems, Minneapolis, MN, US).

Methylation Study
Bisulfite chemically converts unmethylated cytosine to uracil
but has no effect on methylated cytosine. To determine if
promoter region hypermethylation could be responsible for
the downregulation of RASSF1A expression, direct bisulfite
sequencing on mouse cardiac fibroblasts was performed (17). The
methylation ratio (meth-ratio) was calculated using methylated
CpG total CpG counts.

RASSF1A Methylation Analysis
Briefly, the genomic DNA from mouse heart was isolated using
the TRIzol solution (Invitrogen, Thermo Fisher Scientific Inc),
according to the manufacturer’s protocols. The methylation
status of the RASSF1A promoter region was determined by
chemical modification of genomic DNA with sodium bisulfite
and methylation-specific PCR. The bisulfite-treated DNA was
used as a template for the methylation-specific PCR reaction.
Primers for the unmethylated DNA-specific reaction were F, 5VGGTGTTGAAGTTGTGGTTTG-3V; R, 5V-TATTATACCCAA
AACAATACAC-3V. Primers for the methylated DNA-specific
reaction were F, 5V-TTTTGCGGTTTCGTTCGTTC-3V; R,
5V-CCCGAAACGTACTACTATAAC-3V. The reactions were
incubated at 95◦ C for 1 min, 55◦ C for 1 min, and 72◦ C for 1 min,
for 35 cycles. The amplified fragment was confirmed by DNA
sequencing. DNA from normal heart was used as a control for
unmethylated RASSF1A. The strategies for RASSF1A sequencing
and the amplicons map Supplementary #1, #2, respectively.

Quantitative Flow Cytometry—Effects of Hypoxia on
Global DNA Methylation Profile
A modular incubator chamber (Billups-Rothenberg, Del Mar,
CA, USA) was used for the cell hypoxia studies and a 1% oxygen
atmosphere maintained using an oxygen sensor (BioSpherix,
Lacona, NY, USA). Cells were maintained in a microenvironment
of 37◦ C, 1% O2 , 5% CO2 , and 100% humidity. To examine the
effects of hypoxia ± EC-SOD overexpression on global DNA
methylation, both transfected and non-transfected MCF were
incubated in hypoxia for 72 h. Control, non-transfected MCF
were maintained in 21% oxygen for 72 h. Post culture, MCF cells
were fixed in Carnoy’s solution prior to 60-min acid hydrolysis
in 1 M HCl at 37◦ C. Following this DNA denaturation step,
cells were then treated with either an anti-5′ methylcytidine
(5MeC) monoclonal antibody (EpiGentek, Catalog No. A-1014)
or a non-specific IgG1 antibody (BD Biosciences, San Jose, CA).
IgG1-negative controls were used at the same concentration as
the primary antibody. Immunostaining was conducted using
an FITC-conjugated rabbit anti-mouse secondary antibody
(Thermo Scientific, Catalog No. 31561). The cells were then
subjected to flow cytometry (BD Biosciences, San Jose, CA) and
the results assessed using CellQuest Pro (BD Biosciences, San
Jose, CA).

Statistics
Data was expressed as the mean ± standard error of the
mean (SEM). Unless otherwise indicated, a one-way or two-way
analysis of variance followed by Bonferroni post-hoc test was
used to assess significance (P < 0.05) using GraphPad Prism 8
(GraphPad Software, Inc, La Jolla, CA).

Proliferation Studies—Effects of Blocking RASSF1A
Expression

RESULTS

The expression of RASSF1A was reduced by transfection
of MCF with small interfering RNA (SiRNA) SiRASSF1A
(Thermo Fisher Scientific, catalog no. 185488) located
on Chr.9: 107551555–107562267 on Build GRCm38MCF,
using Lipofectamine RNAiMAX transfection protocol (Life
Technologies). Effectiveness of the transfection was evaluated
at 24, 48, 72, and 96 h post transfection with western blot
analysis using an antibody specific for RASSF1A (Abcam).
Post-transfection studies showed that RASSF1A expression is
minimal after 72 h of transfection (data are not shown). This
time point was used for cell proliferation assessment in the next
step. Cells were housed in a humidified incubator (37◦ C, 5%
CO2 ) and compared to control MCF, which were transfected
with an empty vector and kept under the same conditions.
After 72 h of transfection, MCF proliferation was assessed by
BrdU (5-bromouridine) incorporation, (Roche Diagnostics,
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A comparison between WT adult mice and TG mice housed in
room air was performed and is shown in Supplementary #3. All
molecular testing showed no significant difference between WT
and TG under normoxic conditions (room air).

EC-SOD Reduces Cardiac Fibrosis
To examine the effects of EC-SOD overexpression on markers of
cardiac fibrosis at the mRNA level, we performed gene expression
analysis using RT-PCR. There was a significant decrease in the
expression of the cardiac fibrosis markers, Collagen 1 (Col1A1)
(Figure 1A), Collagen 3 (Figure 1B), and ASMA (Figure 1C)
in the hypoxic TG, as compared to the hypoxic WT animals
(p < 0.05). The gene expression of Collagen 1, Collagen 3, and
ASMA in hypoxic TG group was not statistically significantly
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FIGURE 1 | RT-PCR for markers of fibrosis—Collagen 1, Collagen 3, and ASMA. Adult male C57B6 mice, WT, and EC-SOD transgenic mice (TG) were exposed to
FiO2 10% hypoxia for 21 days (WT). The control group was composed of animals housed in room air (RA). Quantitative RT-PCR was used to assess gene expression
analysis of Collagen 1 (A), Collagen 3 (B), and ASMA (C) in the right ventricular tissue. All experiments n = 5. Data represents mean ± SEM. *P < 0.05, **P < 0.01,
***P < 0.001, ****P < 0.0001.

methylating enzymes, using Western blot analysis. There was a
significant decrease in the DNA methylating enzymes, DNMT1
(Figure 5A) and DNMT-3b (Figure 5B), in the hypoxic TG
animals compared to the hypoxic WT animals (p < 0.05). The
levels of HIF1α (Figure 5C) were also noted to be significantly
reduced in the hypoxic TG animals when compared to the WT
animals in hypoxia (p < 0.05). However, the levels in the hypoxic
TG animals were not significantly different when compared to
the TG room air group. Assay of free reactive oxygen species
accumulation by DCF assay showed a significant increase of ROS
in the WT hypoxic group, with ROS levels being significantly
lower in the TG hypoxic group (Figure 5D). Thus, EC-SOD
overexpression decreases DNA methylation, HIF1α, and ROS
in-vivo under hypoxic conditions.

different from room air controls. These results show that ECSOD overexpression reduces gene expression of cardiac fibrosis
markers to levels comparable to RA groups.
To confirm that protein levels of cardiac fibrosis
markers showed a similar trend to gene expression level,
we performed protein-level assessment using Western blot
analysis. There was a significant increase in the cardiac
fibrosis marker levels of Collagen 1 (Figure 2A), ASMA
(Figure 2B), and SNAIL1 (Figure 2C) in hypoxic WT
animals as compared to hypoxic TG animals (p < 0.05).
The protein concentration of these three markers in the
hypoxia TG animals was not significantly different from the
RA control group. This indicates that EC-SOD overexpression
reduces the protein expression of cardiac fibrosis markers
to levels comparable to RA groups. Immunohistochemistry
staining for Collagen 1 showed a significant decrease in
pixel density of Collagen 1 in the hypoxic TG animals,
as compared to the hypoxic WT animals (Figures 3A,B)
(P < 0.05).

EC-SOD Ameliorates the Hypoxia-Induced
Epigenetic Modifications to RASSF1A
Through the Ras/ERK Pathway

EC-SOD Reduces Epigenetic
Modifications—DNA Methylation

We have shown that hypoxia induces epigenetic modifications
both in-vitro and in-vivo. RASSF1A is a tumor suppressor
gene, frequently involved in cardiac fibrosis. DNA methylationmediated silencing of RASSF1A leads to fibroblast proliferation
and cardiac fibrosis. We wanted to examine the effects of ECSOD overexpression on RASSF1A and further examine the
Ras/ERK pathway.
Western blot analysis in the hypoxic WT animals showed
a significant reduction in the gene RASSF1A (Figure 6A), as
compared to both hypoxic TG animals and RA control groups
(p < 0.05). WT hypoxic animals showed a significant increase
of ERK phosphorylation in comparison to the RA control group
(P < 0.05). The level of ERK 1/2 (Figure 6B) was significantly
reduced in the hypoxic TG animals compared to the hypoxic
WT animals.

To examine the effects of EC-SOD on DNA methylation, the
most common form of epigenetic modifications, we transfected
cardiac fibroblast with hEC-SOD and subjected them to
hypoxia. Quantitative flow cytometry studies, using antibody
directed to methylated DNA, revealed a significant increase
in global DNA methylation in cardiac fibroblasts subjected
to hypoxia, compared to cardiac fibroblasts transfected with
hEC-SOD and subjected to the same hypoxic conditions
(p < 0.05) (Figure 4), thus showing that in-vitro, ECSOD significantly decreased global DNA methylation under
hypoxic conditions.
To examine if the same results hold true in the invivo environment, we performed protein assessment of DNA
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FIGURE 2 | Western blot analysis of markers of fibrosis—Collagen 1, ASMA, and SNAIL. Adult mice (C57B6) (WT) and EC-SOD transgenic mice (TG) were exposed
to FiO2 10% hypoxia for 21 days (WT). Room air animals were used as control group (RA). WB analysis was used to assess protein levels of Collagen 1 (A), ASMA
(B), and SNAIL (C) in the right ventricular tissue. All experiments n = 3. Data represents mean ± SEM. *P< 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

RASSF1A Silencing Increase Cardiac
Fibroblast Proliferation

EC-SOD Prevents Myofilament Changes
Myofilament modification induced by hypoxia causes cardiac
dysfunction. Hypoxia can cause switching of Myosin Heavy
chains (MHC) from its alpha (high ATP) to beta isoform low ATP,
thereby decreasing contractility (Figures 7A,B). Gene expression
analysis using RT-PCR showed a significant reduction in the
levels of α-MHC and a significant increase in β-HMC in hypoxic
WT animals as compared to RA groups and hypoxic TG group (P
< 0.05), and this switch was reversed among TG hypoxic group.
This provides evidence of EC-SOD overexpression improving
cardiac contractility.

Frontiers in Cardiovascular Medicine | www.frontiersin.org

To provide further evidence that RASSF1A is involved in cardiac
fibroblast proliferation, we incubated mouse cardiac fibroblast
(MCF), with SiRNA blocking the expression of RASSF1A and
incubated in room air condition, both BrdU assay and cell count
studies were performed. BrDU analysis (Figure 8A) showed a
significant increase in cell proliferation post-transfection with
SiRNA, inhibiting RASSF1A expression, as compared to control
cells also incubated in room air (Figure 8B). There was a
significant increase in cell numbers, with SiRNA silencing
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FIGURE 3 | Immunohistochemistry for Collagen 1. Right ventricular tissue from adult wild-type mice WT and EC-SOD transgenic mice (TG), which were exposed to
FiO2 10% hypoxia for 21 days (WT) and a room air control group (RA) were treated with Cy3 stain to assess for levels of Collagen 1 (A). The images were analyzed
using Fiji image processing software to measure pixel density (B). All experiments n = 5. Data represents mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001,
****P < 0.0001.

methyltransferases and methyl-CpG–binding domain proteins
(MBD) were studied to investigate the possible mechanism
for the observed methylation differences. Evaluated by
RT-PCR normalized to GAPDH, DNMT expression was
significantly higher in hypoxic WT than hypoxic TG cardiac cells
(Figures 5A,B). The methylation level of the RASSFA1 promotor
region (8 amplicons) was significantly higher in the hypoxic WT
group vs. hypoxic TG group (Figures 8C,D). This suggests that
the methylation pattern of the RASSFA1 promoter region may be
attributed to differences in methyl-transferase expression and/or
methyl binding proteins at mRNA level.

DISCUSSION
Free radicals play a key role in the pathogenesis of cardiac
fibrosis [7]. Previously, it has been reported that the free radical
scavenger, EC-SOD, can reduce, as well as reverse, some of the
changes seen secondary to chronic hypoxic stress (19, 24). In
our study, we reported that EC-SOD overexpression leads to a
significant decrease in DNA methylation (DNMT1 and DNMT3b as well as RASSFA1 gene), which is triggered by hypoxia
exposure. Among animals subjected to chronic hypoxia, markers
of fibrosis were increased significantly including RASSFA1
promoter methylation and SNAIL which is involved in fibromodulation. Each of these changes was significantly reversed
when EC-SOD was overexpressed in either in-vitro or in-vivo
model. There was a significant increase in collagen 1, Collagen
3, and ASMA in hypoxic WT animals as compared to animals
housed in room air (P < 0.05) (Figures 1A–C, 2A–C). Similar
data was shown previously using human cardiac tissue [2], and
it was shown that the degree of hypoxia was associated with
increased expression of Collagen 1 and ASMA. In our animal
model, overexpression of EC-SOD offered a significant protective
effect, evident by reduction in the above listed fibrotic markers.
Our data supports the role of oxidative insult induced by hypoxia,

FIGURE 4 | Flow cytometry studies for DNA methylation—In in-vitro studies
using cardiac fibroblasts, DNA methylation levels were assessed in cells
exposed to hypoxic conditions (FiO2 1% for 72 h) and compared to cells
transfected with EC-SOD and exposed to hypoxia. Cells cultured in room air
were employed as controls. Triplicate wells were analyzed, and the
experiments were repeated five times. Data represents mean ± SEM.
*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

RASSF1A, as compared to control cells transfected with an empty
vector. These findings support that silencing RASSF1A, leads to
activation of ERK1/2, which stimulate cell proliferation.

EC-SOD Reduces Cardiac Fibrosis
Through Ameliorating DNA Methylation
To elucidate the mechanism of how EC-SOD reduces cardiac
fibrosis, we show that mRNA expression levels of DNA
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FIGURE 5 | Western blot analysis for DNMT1, 3b, and HIF-1α. Adult mice (WT) and EC-SOD transgenic mice (TG) were exposed to FiO2 10% hypoxia for 21 days.
Room air animals were used as a control group (RA). WB analysis was used to assess protein levels of DNMT 1 (A) and DNMT 3b (B); HIF-1α assessment in cardiac
fibroblasts (C) in the right ventricular tissue. ROS assay in all studied groups (D). All experiments were carried out in triplicate. Data represent mean ± SEM. *P < 0.05,
**P < 0.01, ***P < 0.001, ****P < 0.0001.
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FIGURE 6 | Western blot analysis for RASSF1A and ERK1/2. Adult mice (C57B6) (WT) and EC-SOD transgenic mice (TG), were exposed to 10% hypoxia for 21 days
(WT). Room air animals were used as control group (RA). WB analysis was used to assess protein levels of RASSF1A (A) and ERK1/2 (B) in the right ventricular tissue.
All experiments were carried out in triplicate. Data represents mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

FIGURE 7 | (A,B) RT-PCR for α and β myosin heavy chain. Adult mice (C57B6) (WT) and EC-SOD transgenic mice (TG), were exposed to 10% hypoxia for 21 days
(WT). Room air animals were used as control group (RA). Quantitative RT-PCR was used to assess gene expression analysis of α-MHC in the right ventricular tissue.
All experiments n = 5. Data represents mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

ROS-mediated cardiac fibrosis (25). Mice deficient in SOD2
die of cardiomyopathy within 10 days of birth, whereas
heterozygous SOD2(+/–) mice show ultrastructural damage of
the myocardium and mitochondria, associated with an increased
oxidative stress as well as an activation of apoptotic signaling
pathways in the heart (26, 27). MnSOD overexpression offers
protection against oxidative stress, fibrosis, and apoptosis in the
aging heart (28). Serum EC-SOD activity was independently
associated with abnormal LV geometry patterns with and
without overt HF. Our results indicate that Ec-SOD might
be a potential link between LV structure remodeling and the

in the pathogenesis of cardiac fibrosis. The dismutation of these
free radicals, by overexpression of EC-SOD, leads to reversal
of heart pathology as shown by the immunochemistry studies
(Figures 3A,B).
Many studies showed the role of SOD and its protective role in
animal models with cardiac fibrosis induced by chronic hypoxia,
by scavenging free radicals. SOD1 suppressed MCF proliferation
and differentiation and reduced the production of collagen type
I and III. SOD1 overexpression leads to ROS scavenging and
blocking production and block collagen production, suggesting
that SOD1 may be a promising therapeutic agent for treating
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FIGURE 8 | Cell proliferation studies after transfection with SiRNA for RASSF1A—Cardiac fibroblasts were transfected with SiRNA for RASSF1A and compared to
cells placed in RA which served as a control. BrdU cell proliferation studies were undertaken (A), and cells as having underwent cell counts (B). DNA methylation
studies of the RASSF1A promotor region as shown in the heat map: RA group (samples 1–4); WT hypoxic group (Samples 6–9); TG hypoxic group (samples 11–15)
(C). Quantitative estimation of methylation level among the three studied groups (D). Proposed mechanism (E). Data represent mean ± SEM. *P < 0.05, **P < 0.01,
***P < 0.001, ****P < 0.0001.
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Hypoxia-induced DNA methylation has been shown to be
involved in regulating the process of cardiac fibrosis (2, 35). DNA
methylation mediated silencing of the RASSF1A gene, which
leads to upregulation of ERK1/2 that has been shown to increase
cardiac fibrosis in cancer patients under chronic hypoxic stress
(6, 36). Our data showed a significant increase of ERK1/2 in
the hypoxic animal group in parallel with a significant increase
of DNA methylation and a reduction of RASSF1A expression
(Figure 6A). In adult cardiomyocytes, the high level of H2 O2
is associated with the activation of ERK1/2 MAPK and the
stimulation of protein synthesis (37). Increased ERK1/2 activity
leads to increased cell proliferation and collagen gene expression
in activated cardiac fibroblasts [4]. Dismutation of the free
radicals by the activity of EC-SOD leads to a global decrease of
DNA methylation, increased RASSF1A protein synthesis, and a
significant reduction in phosphorylated ERK1/2 in the transgenic
hypoxic animal group (P < 0.05). This finding suggests an
additional contributing mechanism to cardiac dysfunction in
hypoxia, which is triggered by a change in myosin heavy chain
isoform (38). Previously, it has been shown that hypoxia leads
to a change in MHC from the α to β isoform, which leads
to decreased cardiac contractility (37). Free radicals have been
shown to affect this change and scavenging these free radicals
by antioxidants can markedly attenuate cardiac fibrosis and
improve ventricular ejection fraction and fractional shortening
(38). In our study, there was a significant reduction in the
levels of α-MHC (Figure 7A) and significant increase in b-MHC
(Figure 7B), in hypoxic WT animals as compared to the hypoxia
TG group as shown in the RT-PCT assay. Hypoxia TG animals
had both α&β-MHC levels close to RA controls. This critical
histological change is crucial in preserving cardiac contractility
and function.
We have shown that TG animals that have an additional
copy of the EC-SOD gene show a significant reduction in DNA
methylation in response to chronic hypoxic stress. While further
studies are needed to completely clarify the mechanism, we
speculate that this reduction in DNA methylation is through a
reduction in the levels of HIF-1α, which is an inducer of DNMT
and hence of the process of DNA methylation (6). Our data
show a significant reduction in HIF-1α levels in the animals that
overexpress EC-SOD (P < 0.05) (Figure 5C). This suggests a
mechanism by which DNA methylation leads to cardiac fibrosis.
Both these changes were mitigated in our transgenic animals,
which overexpress EC-SOD.
To further explore the role of RASSF1A in cardiac fibrosis,
its expression was blocked in an in-vitro model using SiRNA.
The presence of the SiRNA resulted in a significant increase
in fibroblast proliferation (Figures 8A,B). Furthermore, we
investigated RASSF1A promoter gene methylation in the three
studied groups. Our findings showed a significant increase in
RASSF1A promotor region methylation in the hypoxic WT
group compared to normoxic animals. This methylation process
was reduced by more than 10% among the hypoxic TG animals,
which showed a significant reduction of both biochemical and
histopathological evidence of cardiac fibrosis.
Epigenetic inactivation of RASSF1A by methylation is a
very common event in prostate cancer and might be involved

development of subsequent HF in patients with cardiovascular
disease. Extracellular superoxide dismutase is associated with
left ventricular geometry and heart failure in patients with
cardiovascular disease (29). Under unstressed conditions, ECSOD deficiency had no effect on myocardial total SOD activity
but resulted in small but significant increases in myocardial
fibrosis and ventricular mass. EC-SOD deficiency is associated
with exacerbated myocardial oxidative stress, hypertrophy,
fibrosis, and dysfunction. All these findings indicate that the
distribution of EC-SOD in the extracellular space is critically
important in protecting the heart against pressure overload
(17). In our study, we report an innovative mechanism of
overexpression of EC-SOD. In animal models with cardiac
fibrosis induced by chronic hypoxia, there is a significant
increase of ERK1/2 in the hypoxic animal group in parallel
with a significant increase of DNA methylation and a reduction
of RASSF1A expression. EC-SOD overexpression reverses this
process and leads to significant decreases in DNA methylation
(DNMT1 and DNMT-3b as well as RASSFA1 gene), which is
triggered by chronic hypoxia exposure.
The role of DNA methylation and epigenetic changes
associated with cardiac fibrosis induced by hypoxia was studied
previously (15, 18). Both DNA methyltransferase enzymes
(DNMT1 and DNMT3b), which are regulated by HIF-1α (30)
(Figure 5C), are upregulated by chronic hypoxia (Figures 5A,B).
Their upregulation was associated with increases in all fibrotic
markers examined and a significant reduction in RASSF1A
protein synthesis (Figure 6). In addition, the significant increase
in the expression of both DNMT enzymes was associated
with increased DNA methylation (Figure 6). Epigenetic changes
induced by prolonged hypoxia have been shown to contribute
to the pro-fibrotic nature of the ischemic environment (2). In
normal human lung fibroblasts, there is a significant global
hypermethylation detected in hypoxic fibroblasts relative to
normoxic controls and is accompanied by increased expression
of myofibroblast markers (24).
SNAIL gene expression is a potential target molecule in
cardiac fibrosis after ischemia reperfusion (I/R), injury, and or
oxidative stress insult (31). The SNAIL gene is best known for its
capability to trigger epithelial-to-mesenchymal transition (EMT)
and endothelial to mesenchymal transition (EndMT), which
may contribute to myofibroblast formation (30, 32). SNAIL is
activated by free radicals and mediates the actions of endogenous
TGFβ signals that induce EndMT (33). Injection of a selective
SNAIL inhibitor remarkably suppressed collagen deposition and
cardiac fibrosis in mouse I/R injury and significantly improved
cardiac function and reduced SNAIL expression in-vivo (34).
SNAIL can recruit multiple chromatin enzymes including
LSD1, HDAC1/2, and Suv39H1. These enzymes function in
a highly organized manner to generate heterochromatin and
promote DNA methyltransferase-mediated DNA methylation at
the promoter region (35). Our data showed that a significant
increase of SNAIL expression in the WT hypoxic group was
attenuated in TG animals, which may lead to a disruption of
the connection between SNAIL and these chromatin-modifying
enzymes and may represent a therapeutic target for the treatment
of cardiac fibrosis.
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ETHICS STATEMENT

in the progression of the disease (39). In prostate cancer,
hypomehtylation of BNIP3 and hypermethylation of both ECSOD and RASSF1A were observed. These changes were positively
associated with oxidative stress and inverse associated with
EC-SOD expression. Among patients with prostate cancer, it
was found that glutamate carboxypeptidase II genetic variants
contribute to increased oxidative stress and prostate cancer risk
by modulating the CpG island methylation of Ec-SOD (40).
In summary, our study presents a novel mechanism by which
EC-SOD offers cardiac protection against fibrosis induced by
chronic or prolonged hypoxia. The data identifies a critical role
of EC-SOD in the control of DNA methylation. Our proposed
mechanism, illustrated in Figure 8E, suggests that EC-SOD
expression will chelate the free radicals, induced by hypoxia; as a
result, both HIF-1α and SNAIL gene activation will be decreased
and subsequently methylation enzyme activity will decrease and
RASSF1A gene expression will not be silenced or decreased due
to lack of methylation. RASSF1A expression downregulates the
activity of the ERK1/2 pathway which regulates activation of
both cardiac fibroblast proliferation and transition of endothelial
cells to myofibroblast. Another benefit from using antioxidants
is chelating hydrogen peroxide, which will significantly decrease
the activation of ERK1/2, as it is triggered directly by hydrogen
peroxide concentration. Previously EC-SOD compounds and
its mimetics were used in experimental and clinical trials
to counteract the oxidative stress which was linked to the
pathogenesis of these disorders (41–46). Further studies of this
mechanism could lead to specific inhibition of the pathway in
the clinic to significantly reduce cardiac fibrosis and dramatically
improve the outcome of this devastating condition.
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